Thus, most RA synovial tissues contained a significantly greater fraction of immature blood vessels lacking periendothelial coverage, which were observed from the earliest phases of the disease and were depleted by anti-TNF-α therapy [21]. The gene discussed is TNF; the disease is rheumatoid arthritis.